nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CYP1A2—Dacarbazine—pancreatic cancer	0.0844	0.327	CbGbCtD
Atropine—CYP1A2—Tamoxifen—pancreatic cancer	0.0671	0.26	CbGbCtD
Atropine—CYP1A2—Erlotinib—pancreatic cancer	0.0571	0.221	CbGbCtD
Atropine—CYP1A2—Fluorouracil—pancreatic cancer	0.0495	0.192	CbGbCtD
Atropine—Confusional state—Fluorouracil—pancreatic cancer	0.000559	0.00109	CcSEcCtD
Atropine—Abdominal pain—Sunitinib—pancreatic cancer	0.000555	0.00108	CcSEcCtD
Atropine—Body temperature increased—Sunitinib—pancreatic cancer	0.000555	0.00108	CcSEcCtD
Atropine—Diarrhoea—Erlotinib—pancreatic cancer	0.000555	0.00108	CcSEcCtD
Atropine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000554	0.00108	CcSEcCtD
Atropine—Oedema—Fluorouracil—pancreatic cancer	0.000554	0.00108	CcSEcCtD
Atropine—Hyponatraemia—Epirubicin—pancreatic cancer	0.000551	0.00107	CcSEcCtD
Atropine—Osteoarthritis—Epirubicin—pancreatic cancer	0.000549	0.00107	CcSEcCtD
Atropine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000545	0.00106	CcSEcCtD
Atropine—Dizziness—Tamoxifen—pancreatic cancer	0.000542	0.00106	CcSEcCtD
Atropine—Tachycardia—Fluorouracil—pancreatic cancer	0.000541	0.00105	CcSEcCtD
Atropine—Hypotension—Irinotecan—pancreatic cancer	0.000541	0.00105	CcSEcCtD
Atropine—Dizziness—Erlotinib—pancreatic cancer	0.000537	0.00105	CcSEcCtD
Atropine—Hypotension—Gemcitabine—pancreatic cancer	0.000527	0.00103	CcSEcCtD
Atropine—Insomnia—Irinotecan—pancreatic cancer	0.000523	0.00102	CcSEcCtD
Atropine—Flushing—Docetaxel—pancreatic cancer	0.000523	0.00102	CcSEcCtD
Atropine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000522	0.00102	CcSEcCtD
Atropine—Vomiting—Tamoxifen—pancreatic cancer	0.000521	0.00102	CcSEcCtD
Atropine—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00052	0.00101	CcSEcCtD
Atropine—Lethargy—Doxorubicin—pancreatic cancer	0.000518	0.00101	CcSEcCtD
Atropine—Hypotension—Fluorouracil—pancreatic cancer	0.000518	0.00101	CcSEcCtD
Atropine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000518	0.00101	CcSEcCtD
Atropine—Rash—Tamoxifen—pancreatic cancer	0.000517	0.00101	CcSEcCtD
Atropine—Dermatitis—Tamoxifen—pancreatic cancer	0.000517	0.00101	CcSEcCtD
Atropine—Ataxia—Epirubicin—pancreatic cancer	0.000516	0.00101	CcSEcCtD
Atropine—Vomiting—Erlotinib—pancreatic cancer	0.000516	0.00101	CcSEcCtD
Atropine—Dyspnoea—Irinotecan—pancreatic cancer	0.000516	0.00101	CcSEcCtD
Atropine—Somnolence—Irinotecan—pancreatic cancer	0.000514	0.001	CcSEcCtD
Atropine—Headache—Tamoxifen—pancreatic cancer	0.000514	0.001	CcSEcCtD
Atropine—Rash—Erlotinib—pancreatic cancer	0.000512	0.000998	CcSEcCtD
Atropine—Dermatitis—Erlotinib—pancreatic cancer	0.000511	0.000997	CcSEcCtD
Atropine—Dehydration—Epirubicin—pancreatic cancer	0.000511	0.000996	CcSEcCtD
Atropine—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00051	0.000994	CcSEcCtD
Atropine—Insomnia—Gemcitabine—pancreatic cancer	0.00051	0.000994	CcSEcCtD
Atropine—Dyspepsia—Irinotecan—pancreatic cancer	0.000509	0.000993	CcSEcCtD
Atropine—Headache—Erlotinib—pancreatic cancer	0.000508	0.000991	CcSEcCtD
Atropine—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000508	0.00099	CcSEcCtD
Atropine—Asthenia—Sunitinib—pancreatic cancer	0.000504	0.000983	CcSEcCtD
Atropine—Dry skin—Epirubicin—pancreatic cancer	0.000503	0.000981	CcSEcCtD
Atropine—Arrhythmia—Docetaxel—pancreatic cancer	0.000503	0.000981	CcSEcCtD
Atropine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000503	0.00098	CcSEcCtD
Atropine—Insomnia—Fluorouracil—pancreatic cancer	0.000501	0.000977	CcSEcCtD
Atropine—Somnolence—Gemcitabine—pancreatic cancer	0.000501	0.000977	CcSEcCtD
Atropine—Hypokalaemia—Epirubicin—pancreatic cancer	0.0005	0.000974	CcSEcCtD
Atropine—Fatigue—Irinotecan—pancreatic cancer	0.000499	0.000973	CcSEcCtD
Atropine—Pruritus—Sunitinib—pancreatic cancer	0.000497	0.000969	CcSEcCtD
Atropine—Pain—Irinotecan—pancreatic cancer	0.000495	0.000965	CcSEcCtD
Atropine—Constipation—Irinotecan—pancreatic cancer	0.000495	0.000965	CcSEcCtD
Atropine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000494	0.000964	CcSEcCtD
Atropine—Mental disorder—Docetaxel—pancreatic cancer	0.000493	0.000962	CcSEcCtD
Atropine—Somnolence—Fluorouracil—pancreatic cancer	0.000493	0.000961	CcSEcCtD
Atropine—Erythema—Docetaxel—pancreatic cancer	0.00049	0.000956	CcSEcCtD
Atropine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000488	0.000951	CcSEcCtD
Atropine—Nausea—Tamoxifen—pancreatic cancer	0.000487	0.00095	CcSEcCtD
Atropine—Fatigue—Gemcitabine—pancreatic cancer	0.000486	0.000948	CcSEcCtD
Atropine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000483	0.000942	CcSEcCtD
Atropine—Pain—Gemcitabine—pancreatic cancer	0.000482	0.00094	CcSEcCtD
Atropine—Constipation—Gemcitabine—pancreatic cancer	0.000482	0.00094	CcSEcCtD
Atropine—Nausea—Erlotinib—pancreatic cancer	0.000482	0.00094	CcSEcCtD
Atropine—Diarrhoea—Sunitinib—pancreatic cancer	0.000481	0.000937	CcSEcCtD
Atropine—Dysgeusia—Docetaxel—pancreatic cancer	0.00048	0.000936	CcSEcCtD
Atropine—Abdominal distension—Epirubicin—pancreatic cancer	0.000478	0.000931	CcSEcCtD
Atropine—Ataxia—Doxorubicin—pancreatic cancer	0.000478	0.000931	CcSEcCtD
Atropine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000477	0.00093	CcSEcCtD
Atropine—Dysphagia—Epirubicin—pancreatic cancer	0.000474	0.000925	CcSEcCtD
Atropine—Pain—Fluorouracil—pancreatic cancer	0.000474	0.000924	CcSEcCtD
Atropine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000473	0.000923	CcSEcCtD
Atropine—Dehydration—Doxorubicin—pancreatic cancer	0.000472	0.000921	CcSEcCtD
Atropine—Dry skin—Doxorubicin—pancreatic cancer	0.000466	0.000908	CcSEcCtD
Atropine—Dizziness—Sunitinib—pancreatic cancer	0.000465	0.000906	CcSEcCtD
Atropine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000464	0.000906	CcSEcCtD
Atropine—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000462	0.000901	CcSEcCtD
Atropine—Angina pectoris—Epirubicin—pancreatic cancer	0.000462	0.000901	CcSEcCtD
Atropine—Abdominal pain—Irinotecan—pancreatic cancer	0.000457	0.000892	CcSEcCtD
Atropine—Body temperature increased—Irinotecan—pancreatic cancer	0.000457	0.000892	CcSEcCtD
Atropine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000457	0.000891	CcSEcCtD
Atropine—Vomiting—Sunitinib—pancreatic cancer	0.000447	0.000871	CcSEcCtD
Atropine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000446	0.000869	CcSEcCtD
Atropine—Dysuria—Epirubicin—pancreatic cancer	0.000444	0.000865	CcSEcCtD
Atropine—Rash—Sunitinib—pancreatic cancer	0.000443	0.000864	CcSEcCtD
Atropine—Dermatitis—Sunitinib—pancreatic cancer	0.000443	0.000863	CcSEcCtD
Atropine—Abdominal distension—Doxorubicin—pancreatic cancer	0.000442	0.000862	CcSEcCtD
Atropine—Urticaria—Fluorouracil—pancreatic cancer	0.00044	0.000859	CcSEcCtD
Atropine—Headache—Sunitinib—pancreatic cancer	0.00044	0.000858	CcSEcCtD
Atropine—Syncope—Docetaxel—pancreatic cancer	0.00044	0.000857	CcSEcCtD
Atropine—Dysphagia—Doxorubicin—pancreatic cancer	0.000439	0.000856	CcSEcCtD
Atropine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000438	0.000854	CcSEcCtD
Atropine—Palpitations—Docetaxel—pancreatic cancer	0.000433	0.000845	CcSEcCtD
Atropine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000431	0.00084	CcSEcCtD
Atropine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000428	0.000835	CcSEcCtD
Atropine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000428	0.000834	CcSEcCtD
Atropine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000426	0.000831	CcSEcCtD
Atropine—Convulsion—Docetaxel—pancreatic cancer	0.000425	0.000828	CcSEcCtD
Atropine—Drowsiness—Epirubicin—pancreatic cancer	0.000423	0.000825	CcSEcCtD
Atropine—Chest pain—Docetaxel—pancreatic cancer	0.000417	0.000814	CcSEcCtD
Atropine—Nausea—Sunitinib—pancreatic cancer	0.000417	0.000814	CcSEcCtD
Atropine—Asthenia—Irinotecan—pancreatic cancer	0.000415	0.00081	CcSEcCtD
Atropine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000411	0.000802	CcSEcCtD
Atropine—Dysuria—Doxorubicin—pancreatic cancer	0.000411	0.000801	CcSEcCtD
Atropine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000408	0.000796	CcSEcCtD
Atropine—Dry mouth—Docetaxel—pancreatic cancer	0.000408	0.000796	CcSEcCtD
Atropine—Sweating—Epirubicin—pancreatic cancer	0.000406	0.000791	CcSEcCtD
Atropine—Asthenia—Gemcitabine—pancreatic cancer	0.000404	0.000789	CcSEcCtD
Atropine—Confusional state—Docetaxel—pancreatic cancer	0.000403	0.000787	CcSEcCtD
Atropine—Oedema—Docetaxel—pancreatic cancer	0.0004	0.00078	CcSEcCtD
Atropine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.0004	0.00078	CcSEcCtD
Atropine—Pruritus—Gemcitabine—pancreatic cancer	0.000399	0.000778	CcSEcCtD
Atropine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000396	0.000772	CcSEcCtD
Atropine—Diarrhoea—Irinotecan—pancreatic cancer	0.000396	0.000772	CcSEcCtD
Atropine—Shock—Docetaxel—pancreatic cancer	0.000394	0.000767	CcSEcCtD
Atropine—Pruritus—Fluorouracil—pancreatic cancer	0.000392	0.000765	CcSEcCtD
Atropine—Drowsiness—Doxorubicin—pancreatic cancer	0.000391	0.000763	CcSEcCtD
Atropine—Tachycardia—Docetaxel—pancreatic cancer	0.00039	0.000761	CcSEcCtD
Atropine—Bradycardia—Epirubicin—pancreatic cancer	0.000387	0.000754	CcSEcCtD
Atropine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000386	0.000752	CcSEcCtD
Atropine—Dizziness—Irinotecan—pancreatic cancer	0.000383	0.000746	CcSEcCtD
Atropine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00038	0.000742	CcSEcCtD
Atropine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000379	0.000739	CcSEcCtD
Atropine—Sweating—Doxorubicin—pancreatic cancer	0.000375	0.000732	CcSEcCtD
Atropine—Hypotension—Docetaxel—pancreatic cancer	0.000374	0.000729	CcSEcCtD
Atropine—Vomiting—Irinotecan—pancreatic cancer	0.000368	0.000717	CcSEcCtD
Atropine—Dizziness—Fluorouracil—pancreatic cancer	0.000366	0.000715	CcSEcCtD
Atropine—Rash—Irinotecan—pancreatic cancer	0.000365	0.000711	CcSEcCtD
Atropine—Dermatitis—Irinotecan—pancreatic cancer	0.000365	0.000711	CcSEcCtD
Atropine—Headache—Irinotecan—pancreatic cancer	0.000363	0.000707	CcSEcCtD
Atropine—Insomnia—Docetaxel—pancreatic cancer	0.000362	0.000706	CcSEcCtD
Atropine—Vomiting—Gemcitabine—pancreatic cancer	0.000358	0.000699	CcSEcCtD
Atropine—Bradycardia—Doxorubicin—pancreatic cancer	0.000358	0.000698	CcSEcCtD
Atropine—Dyspnoea—Docetaxel—pancreatic cancer	0.000357	0.000695	CcSEcCtD
Atropine—Somnolence—Docetaxel—pancreatic cancer	0.000356	0.000693	CcSEcCtD
Atropine—Rash—Gemcitabine—pancreatic cancer	0.000355	0.000693	CcSEcCtD
Atropine—Dermatitis—Gemcitabine—pancreatic cancer	0.000355	0.000692	CcSEcCtD
Atropine—Headache—Gemcitabine—pancreatic cancer	0.000353	0.000689	CcSEcCtD
Atropine—Flushing—Epirubicin—pancreatic cancer	0.000352	0.000687	CcSEcCtD
Atropine—Vomiting—Fluorouracil—pancreatic cancer	0.000352	0.000687	CcSEcCtD
Atropine—Dyspepsia—Docetaxel—pancreatic cancer	0.000352	0.000687	CcSEcCtD
Atropine—Rash—Fluorouracil—pancreatic cancer	0.000349	0.000681	CcSEcCtD
Atropine—Dermatitis—Fluorouracil—pancreatic cancer	0.000349	0.000681	CcSEcCtD
Atropine—Headache—Fluorouracil—pancreatic cancer	0.000347	0.000677	CcSEcCtD
Atropine—Fatigue—Docetaxel—pancreatic cancer	0.000345	0.000673	CcSEcCtD
Atropine—Nausea—Irinotecan—pancreatic cancer	0.000344	0.00067	CcSEcCtD
Atropine—Constipation—Docetaxel—pancreatic cancer	0.000342	0.000667	CcSEcCtD
Atropine—Pain—Docetaxel—pancreatic cancer	0.000342	0.000667	CcSEcCtD
Atropine—Arrhythmia—Epirubicin—pancreatic cancer	0.000339	0.000662	CcSEcCtD
Atropine—Nausea—Gemcitabine—pancreatic cancer	0.000335	0.000653	CcSEcCtD
Atropine—Mental disorder—Epirubicin—pancreatic cancer	0.000333	0.000649	CcSEcCtD
Atropine—Erythema—Epirubicin—pancreatic cancer	0.000331	0.000645	CcSEcCtD
Atropine—Feeling abnormal—Docetaxel—pancreatic cancer	0.00033	0.000643	CcSEcCtD
Atropine—Nausea—Fluorouracil—pancreatic cancer	0.000329	0.000642	CcSEcCtD
Atropine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000327	0.000638	CcSEcCtD
Atropine—Flushing—Doxorubicin—pancreatic cancer	0.000326	0.000636	CcSEcCtD
Atropine—Tension—Epirubicin—pancreatic cancer	0.000324	0.000633	CcSEcCtD
Atropine—Dysgeusia—Epirubicin—pancreatic cancer	0.000324	0.000631	CcSEcCtD
Atropine—Nervousness—Epirubicin—pancreatic cancer	0.000321	0.000626	CcSEcCtD
Atropine—Abdominal pain—Docetaxel—pancreatic cancer	0.000316	0.000617	CcSEcCtD
Atropine—Body temperature increased—Docetaxel—pancreatic cancer	0.000316	0.000617	CcSEcCtD
Atropine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000314	0.000612	CcSEcCtD
Atropine—Vision blurred—Epirubicin—pancreatic cancer	0.000312	0.000608	CcSEcCtD
Atropine—Mental disorder—Doxorubicin—pancreatic cancer	0.000308	0.0006	CcSEcCtD
Atropine—Erythema—Doxorubicin—pancreatic cancer	0.000306	0.000596	CcSEcCtD
Atropine—Agitation—Epirubicin—pancreatic cancer	0.000304	0.000592	CcSEcCtD
Atropine—Tension—Doxorubicin—pancreatic cancer	0.0003	0.000585	CcSEcCtD
Atropine—Dysgeusia—Doxorubicin—pancreatic cancer	0.0003	0.000584	CcSEcCtD
Atropine—Nervousness—Doxorubicin—pancreatic cancer	0.000297	0.000579	CcSEcCtD
Atropine—Vertigo—Epirubicin—pancreatic cancer	0.000297	0.000579	CcSEcCtD
Atropine—Syncope—Epirubicin—pancreatic cancer	0.000296	0.000578	CcSEcCtD
Atropine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000295	0.000575	CcSEcCtD
Atropine—Palpitations—Epirubicin—pancreatic cancer	0.000292	0.00057	CcSEcCtD
Atropine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000291	0.000567	CcSEcCtD
Atropine—Vision blurred—Doxorubicin—pancreatic cancer	0.000288	0.000562	CcSEcCtD
Atropine—Asthenia—Docetaxel—pancreatic cancer	0.000287	0.00056	CcSEcCtD
Atropine—Convulsion—Epirubicin—pancreatic cancer	0.000286	0.000559	CcSEcCtD
Atropine—Pruritus—Docetaxel—pancreatic cancer	0.000283	0.000552	CcSEcCtD
Atropine—Chest pain—Epirubicin—pancreatic cancer	0.000281	0.000549	CcSEcCtD
Atropine—Agitation—Doxorubicin—pancreatic cancer	0.000281	0.000548	CcSEcCtD
Atropine—Anxiety—Epirubicin—pancreatic cancer	0.00028	0.000547	CcSEcCtD
Atropine—Dry mouth—Epirubicin—pancreatic cancer	0.000275	0.000537	CcSEcCtD
Atropine—Vertigo—Doxorubicin—pancreatic cancer	0.000275	0.000536	CcSEcCtD
Atropine—Syncope—Doxorubicin—pancreatic cancer	0.000274	0.000535	CcSEcCtD
Atropine—Diarrhoea—Docetaxel—pancreatic cancer	0.000274	0.000534	CcSEcCtD
Atropine—Confusional state—Epirubicin—pancreatic cancer	0.000272	0.000531	CcSEcCtD
Atropine—Palpitations—Doxorubicin—pancreatic cancer	0.00027	0.000527	CcSEcCtD
Atropine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00027	0.000526	CcSEcCtD
Atropine—Oedema—Epirubicin—pancreatic cancer	0.00027	0.000526	CcSEcCtD
Atropine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000269	0.000524	CcSEcCtD
Atropine—Shock—Epirubicin—pancreatic cancer	0.000265	0.000518	CcSEcCtD
Atropine—Convulsion—Doxorubicin—pancreatic cancer	0.000265	0.000517	CcSEcCtD
Atropine—Dizziness—Docetaxel—pancreatic cancer	0.000265	0.000516	CcSEcCtD
Atropine—Tachycardia—Epirubicin—pancreatic cancer	0.000263	0.000513	CcSEcCtD
Atropine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000261	0.000509	CcSEcCtD
Atropine—Chest pain—Doxorubicin—pancreatic cancer	0.00026	0.000508	CcSEcCtD
Atropine—Anxiety—Doxorubicin—pancreatic cancer	0.00026	0.000506	CcSEcCtD
Atropine—Dry mouth—Doxorubicin—pancreatic cancer	0.000255	0.000497	CcSEcCtD
Atropine—Vomiting—Docetaxel—pancreatic cancer	0.000254	0.000496	CcSEcCtD
Atropine—Rash—Docetaxel—pancreatic cancer	0.000252	0.000492	CcSEcCtD
Atropine—Hypotension—Epirubicin—pancreatic cancer	0.000252	0.000492	CcSEcCtD
Atropine—Dermatitis—Docetaxel—pancreatic cancer	0.000252	0.000491	CcSEcCtD
Atropine—Confusional state—Doxorubicin—pancreatic cancer	0.000252	0.000491	CcSEcCtD
Atropine—Headache—Docetaxel—pancreatic cancer	0.000251	0.000489	CcSEcCtD
Atropine—Oedema—Doxorubicin—pancreatic cancer	0.00025	0.000487	CcSEcCtD
Atropine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00025	0.000487	CcSEcCtD
Atropine—Shock—Doxorubicin—pancreatic cancer	0.000246	0.000479	CcSEcCtD
Atropine—Insomnia—Epirubicin—pancreatic cancer	0.000244	0.000476	CcSEcCtD
Atropine—Tachycardia—Doxorubicin—pancreatic cancer	0.000244	0.000475	CcSEcCtD
Atropine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000241	0.000471	CcSEcCtD
Atropine—Dyspnoea—Epirubicin—pancreatic cancer	0.000241	0.000469	CcSEcCtD
Atropine—Somnolence—Epirubicin—pancreatic cancer	0.00024	0.000468	CcSEcCtD
Atropine—Nausea—Docetaxel—pancreatic cancer	0.000238	0.000463	CcSEcCtD
Atropine—Dyspepsia—Epirubicin—pancreatic cancer	0.000237	0.000463	CcSEcCtD
Atropine—Hypotension—Doxorubicin—pancreatic cancer	0.000233	0.000455	CcSEcCtD
Atropine—Fatigue—Epirubicin—pancreatic cancer	0.000233	0.000454	CcSEcCtD
Atropine—Constipation—Epirubicin—pancreatic cancer	0.000231	0.00045	CcSEcCtD
Atropine—Pain—Epirubicin—pancreatic cancer	0.000231	0.00045	CcSEcCtD
Atropine—Insomnia—Doxorubicin—pancreatic cancer	0.000226	0.00044	CcSEcCtD
Atropine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000223	0.000434	CcSEcCtD
Atropine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000222	0.000434	CcSEcCtD
Atropine—Somnolence—Doxorubicin—pancreatic cancer	0.000222	0.000433	CcSEcCtD
Atropine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000221	0.00043	CcSEcCtD
Atropine—Dyspepsia—Doxorubicin—pancreatic cancer	0.00022	0.000429	CcSEcCtD
Atropine—Fatigue—Doxorubicin—pancreatic cancer	0.000215	0.00042	CcSEcCtD
Atropine—Urticaria—Epirubicin—pancreatic cancer	0.000214	0.000418	CcSEcCtD
Atropine—Constipation—Doxorubicin—pancreatic cancer	0.000213	0.000416	CcSEcCtD
Atropine—Pain—Doxorubicin—pancreatic cancer	0.000213	0.000416	CcSEcCtD
Atropine—Abdominal pain—Epirubicin—pancreatic cancer	0.000213	0.000416	CcSEcCtD
Atropine—Body temperature increased—Epirubicin—pancreatic cancer	0.000213	0.000416	CcSEcCtD
Atropine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000206	0.000401	CcSEcCtD
Atropine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000204	0.000398	CcSEcCtD
Atropine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000199	0.000388	CcSEcCtD
Atropine—Urticaria—Doxorubicin—pancreatic cancer	0.000198	0.000387	CcSEcCtD
Atropine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000197	0.000385	CcSEcCtD
Atropine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000197	0.000385	CcSEcCtD
Atropine—Asthenia—Epirubicin—pancreatic cancer	0.000194	0.000377	CcSEcCtD
Atropine—Pruritus—Epirubicin—pancreatic cancer	0.000191	0.000372	CcSEcCtD
Atropine—Diarrhoea—Epirubicin—pancreatic cancer	0.000185	0.00036	CcSEcCtD
Atropine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000184	0.000359	CcSEcCtD
Atropine—Asthenia—Doxorubicin—pancreatic cancer	0.000179	0.000349	CcSEcCtD
Atropine—Dizziness—Epirubicin—pancreatic cancer	0.000178	0.000348	CcSEcCtD
Atropine—Pruritus—Doxorubicin—pancreatic cancer	0.000177	0.000344	CcSEcCtD
Atropine—Vomiting—Epirubicin—pancreatic cancer	0.000172	0.000335	CcSEcCtD
Atropine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000171	0.000333	CcSEcCtD
Atropine—Rash—Epirubicin—pancreatic cancer	0.00017	0.000332	CcSEcCtD
Atropine—Dermatitis—Epirubicin—pancreatic cancer	0.00017	0.000331	CcSEcCtD
Atropine—Headache—Epirubicin—pancreatic cancer	0.000169	0.00033	CcSEcCtD
Atropine—Dizziness—Doxorubicin—pancreatic cancer	0.000165	0.000322	CcSEcCtD
Atropine—Nausea—Epirubicin—pancreatic cancer	0.00016	0.000313	CcSEcCtD
Atropine—Vomiting—Doxorubicin—pancreatic cancer	0.000159	0.00031	CcSEcCtD
Atropine—Rash—Doxorubicin—pancreatic cancer	0.000157	0.000307	CcSEcCtD
Atropine—Dermatitis—Doxorubicin—pancreatic cancer	0.000157	0.000307	CcSEcCtD
Atropine—Headache—Doxorubicin—pancreatic cancer	0.000156	0.000305	CcSEcCtD
Atropine—Nausea—Doxorubicin—pancreatic cancer	0.000148	0.000289	CcSEcCtD
Atropine—CHRM4—Signaling Pathways—HIF1A—pancreatic cancer	5.05e-05	0.00022	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TSC2—pancreatic cancer	5.04e-05	0.00022	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GCG—pancreatic cancer	5.04e-05	0.00022	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	5.01e-05	0.000219	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GCG—pancreatic cancer	4.99e-05	0.000218	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—APOE—pancreatic cancer	4.93e-05	0.000215	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.92e-05	0.000214	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.9e-05	0.000214	CbGpPWpGaD
Atropine—CHRM3—Metabolism—TYMS—pancreatic cancer	4.87e-05	0.000213	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.85e-05	0.000212	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HIF1A—pancreatic cancer	4.84e-05	0.000211	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KDR—pancreatic cancer	4.83e-05	0.000211	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TSC2—pancreatic cancer	4.82e-05	0.00021	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	4.82e-05	0.00021	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	4.81e-05	0.00021	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	4.76e-05	0.000208	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—STK11—pancreatic cancer	4.75e-05	0.000207	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—STK11—pancreatic cancer	4.74e-05	0.000207	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—APOE—pancreatic cancer	4.72e-05	0.000206	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—STK11—pancreatic cancer	4.69e-05	0.000205	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KDR—pancreatic cancer	4.62e-05	0.000202	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NFKBIA—pancreatic cancer	4.59e-05	0.0002	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NOTCH1—pancreatic cancer	4.55e-05	0.000198	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.51e-05	0.000197	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	4.46e-05	0.000195	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	4.45e-05	0.000194	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CG—pancreatic cancer	4.45e-05	0.000194	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—NRAS—pancreatic cancer	4.45e-05	0.000194	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	4.41e-05	0.000192	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	4.4e-05	0.000192	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NFKBIA—pancreatic cancer	4.4e-05	0.000192	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EGF—pancreatic cancer	4.4e-05	0.000192	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NOTCH1—pancreatic cancer	4.36e-05	0.00019	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—DPYD—pancreatic cancer	4.33e-05	0.000189	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.28e-05	0.000187	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.27e-05	0.000186	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CG—pancreatic cancer	4.26e-05	0.000186	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—NRAS—pancreatic cancer	4.26e-05	0.000186	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.23e-05	0.000185	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EGF—pancreatic cancer	4.21e-05	0.000184	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	4.16e-05	0.000182	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	4.15e-05	0.000181	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	4.12e-05	0.00018	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	4.11e-05	0.000179	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	4.11e-05	0.000179	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	4.1e-05	0.000179	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.07e-05	0.000177	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	4.06e-05	0.000177	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HES1—pancreatic cancer	4.06e-05	0.000177	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—EGFR—pancreatic cancer	4.05e-05	0.000177	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HES1—pancreatic cancer	4.05e-05	0.000177	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HES1—pancreatic cancer	4.01e-05	0.000175	CbGpPWpGaD
Atropine—CHRM3—Metabolism—APOE—pancreatic cancer	3.96e-05	0.000173	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.93e-05	0.000171	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CD—pancreatic cancer	3.91e-05	0.000171	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	3.89e-05	0.00017	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—EGFR—pancreatic cancer	3.88e-05	0.000169	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	3.88e-05	0.000169	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.87e-05	0.000169	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	3.84e-05	0.000168	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—KRAS—pancreatic cancer	3.83e-05	0.000167	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CD—pancreatic cancer	3.75e-05	0.000163	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	3.74e-05	0.000163	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	3.73e-05	0.000163	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.71e-05	0.000162	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	3.69e-05	0.000161	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—KRAS—pancreatic cancer	3.67e-05	0.00016	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CG—pancreatic cancer	3.58e-05	0.000156	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.58e-05	0.000156	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TERT—pancreatic cancer	3.56e-05	0.000155	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TERT—pancreatic cancer	3.55e-05	0.000155	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—PIK3CA—pancreatic cancer	3.52e-05	0.000153	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TERT—pancreatic cancer	3.51e-05	0.000153	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPARG—pancreatic cancer	3.45e-05	0.000151	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CB—pancreatic cancer	3.41e-05	0.000149	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	3.4e-05	0.000149	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	3.4e-05	0.000148	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	3.39e-05	0.000148	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	3.39e-05	0.000148	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	3.37e-05	0.000147	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	3.36e-05	0.000147	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	3.35e-05	0.000146	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APOE—pancreatic cancer	3.32e-05	0.000145	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APOE—pancreatic cancer	3.31e-05	0.000145	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	3.28e-05	0.000143	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CXCL8—pancreatic cancer	3.28e-05	0.000143	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CB—pancreatic cancer	3.26e-05	0.000142	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KDR—pancreatic cancer	3.26e-05	0.000142	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—HRAS—pancreatic cancer	3.25e-05	0.000142	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KDR—pancreatic cancer	3.25e-05	0.000142	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	3.21e-05	0.00014	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CD44—pancreatic cancer	3.18e-05	0.000139	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—AKT1—pancreatic cancer	3.16e-05	0.000138	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CD—pancreatic cancer	3.14e-05	0.000137	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CXCL8—pancreatic cancer	3.14e-05	0.000137	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CASP3—pancreatic cancer	3.14e-05	0.000137	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—HRAS—pancreatic cancer	3.12e-05	0.000136	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.12e-05	0.000136	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	3.1e-05	0.000135	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.09e-05	0.000135	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	3.09e-05	0.000135	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	3.07e-05	0.000134	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	3.06e-05	0.000133	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	3.06e-05	0.000133	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCND1—pancreatic cancer	3.05e-05	0.000133	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GCG—pancreatic cancer	3.05e-05	0.000133	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—AKT1—pancreatic cancer	3.03e-05	0.000132	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	3.03e-05	0.000132	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CTNNB1—pancreatic cancer	3.02e-05	0.000132	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CASP3—pancreatic cancer	3e-05	0.000131	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	3e-05	0.000131	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	3e-05	0.000131	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	2.99e-05	0.00013	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	2.99e-05	0.00013	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EGF—pancreatic cancer	2.97e-05	0.000129	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MMP9—pancreatic cancer	2.96e-05	0.000129	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	2.96e-05	0.000129	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	2.96e-05	0.000129	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EGF—pancreatic cancer	2.96e-05	0.000129	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PTEN—pancreatic cancer	2.95e-05	0.000129	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	2.93e-05	0.000128	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCND1—pancreatic cancer	2.92e-05	0.000128	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CTNNB1—pancreatic cancer	2.89e-05	0.000126	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—AKT1—pancreatic cancer	2.87e-05	0.000125	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—STK11—pancreatic cancer	2.87e-05	0.000125	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MMP9—pancreatic cancer	2.84e-05	0.000124	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PTEN—pancreatic cancer	2.82e-05	0.000123	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—AKT1—pancreatic cancer	2.75e-05	0.00012	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CB—pancreatic cancer	2.74e-05	0.00012	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	2.73e-05	0.000119	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SRC—pancreatic cancer	2.73e-05	0.000119	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	2.72e-05	0.000119	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTGS2—pancreatic cancer	2.72e-05	0.000118	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	2.7e-05	0.000118	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.69e-05	0.000118	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—pancreatic cancer	2.66e-05	0.000116	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	2.64e-05	0.000115	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—STAT3—pancreatic cancer	2.63e-05	0.000115	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	2.63e-05	0.000115	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NRAS—pancreatic cancer	2.63e-05	0.000115	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SRC—pancreatic cancer	2.62e-05	0.000114	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.61e-05	0.000114	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.6e-05	0.000114	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	2.6e-05	0.000114	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	2.58e-05	0.000113	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.58e-05	0.000113	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	2.57e-05	0.000112	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	2.55e-05	0.000111	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—pancreatic cancer	2.55e-05	0.000111	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—STAT3—pancreatic cancer	2.52e-05	0.00011	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NRAS—pancreatic cancer	2.52e-05	0.00011	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.47e-05	0.000108	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MYC—pancreatic cancer	2.45e-05	0.000107	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TGFB1—pancreatic cancer	2.44e-05	0.000107	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EGFR—pancreatic cancer	2.39e-05	0.000104	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.37e-05	0.000103	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTEN—pancreatic cancer	2.37e-05	0.000103	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	2.36e-05	0.000103	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MYC—pancreatic cancer	2.34e-05	0.000102	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.34e-05	0.000102	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TGFB1—pancreatic cancer	2.34e-05	0.000102	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	2.3e-05	0.0001	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	2.29e-05	0.0001	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	2.29e-05	0.0001	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	2.27e-05	9.9e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KRAS—pancreatic cancer	2.26e-05	9.87e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	2.21e-05	9.64e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	2.2e-05	9.61e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	2.19e-05	9.58e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	2.19e-05	9.54e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	2.18e-05	9.51e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	2.17e-05	9.45e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	2.17e-05	9.45e-05	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	2.13e-05	9.31e-05	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	2.13e-05	9.28e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	2.11e-05	9.22e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	2.11e-05	9.2e-05	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	2.11e-05	9.19e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	2.09e-05	9.11e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CA—pancreatic cancer	2.08e-05	9.07e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	2.06e-05	8.98e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	2.05e-05	8.95e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	2.04e-05	8.89e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	2.03e-05	8.86e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	2.03e-05	8.86e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.01e-05	8.78e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TP53—pancreatic cancer	2.01e-05	8.77e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—APOE—pancreatic cancer	2.01e-05	8.76e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	2e-05	8.72e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	1.99e-05	8.69e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	1.99e-05	8.68e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	1.99e-05	8.67e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	1.98e-05	8.64e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	1.97e-05	8.61e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	1.96e-05	8.55e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.94e-05	8.45e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	1.93e-05	8.43e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TP53—pancreatic cancer	1.93e-05	8.4e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	1.92e-05	8.39e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	1.91e-05	8.35e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.9e-05	8.29e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	1.84e-05	8.04e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	1.84e-05	8.03e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	1.84e-05	8.01e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	1.82e-05	7.93e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.81e-05	7.9e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	1.79e-05	7.83e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	1.79e-05	7.8e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	1.78e-05	7.75e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	1.77e-05	7.73e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	1.77e-05	7.73e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	1.77e-05	7.73e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	1.77e-05	7.71e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	1.75e-05	7.65e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	1.75e-05	7.63e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.75e-05	7.63e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	1.7e-05	7.41e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	1.67e-05	7.29e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	1.65e-05	7.2e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.65e-05	7.18e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	1.65e-05	7.18e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	1.64e-05	7.16e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.63e-05	7.11e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	1.63e-05	7.09e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.63e-05	7.09e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	1.61e-05	7.04e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	1.61e-05	7.02e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.59e-05	6.95e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.59e-05	6.95e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	1.53e-05	6.65e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	1.52e-05	6.63e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.51e-05	6.57e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.4e-05	6.11e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	1.4e-05	6.09e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.39e-05	6.06e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.38e-05	6.04e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.38e-05	6e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AKT1—pancreatic cancer	1.36e-05	5.95e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	1.36e-05	5.91e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	1.35e-05	5.9e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.34e-05	5.84e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	1.3e-05	5.66e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	1.29e-05	5.64e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.28e-05	5.58e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.2e-05	5.23e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	1.14e-05	4.99e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	1.14e-05	4.98e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.13e-05	4.93e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	8.46e-06	3.69e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKT1—pancreatic cancer	6.91e-06	3.02e-05	CbGpPWpGaD
